| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 22 |
| 1 | METHOTREXATE SODIUM | 21 |
| 2 | FLUOROURACIL | 20 |
| 3 | FLUOROURACIL CREAM, 0.5% | 20 |
| 4 | TREPROSTINIL | 18 |
| 5 | PREDNISONE | 17 |
| 6 | AMBRISENTAN | 15 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 15 |
| 8 | CYCLOPHOSPHAMIDE | 14 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANORECTAL OINTMENT | 1 | 0.0046 |
| 1 | NATALIZUMAB-SZTN | 1 | 0.0042 |
| 2 | DIMETHYL SULFOXIDE | 1 | 0.0041 |
| 3 | FLUORESCEIN SODIUM | 1 | 0.0032 |
| 4 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 2 | 0.0024 |
| 5 | SODIUM PHENYLBUTYRATE | 1 | 0.0024 |
| 6 | EPINEPHRINE HYDROCHLORIDE | 1 | 0.0021 |
| 7 | GAS RELIEF | 1 | 0.0020 |
| 8 | MENTHOL, METHYL SALICYLATE | 1 | 0.0017 |
| 9 | INAVOLISIB | 1 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 34 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 33 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 32 |
| 3 | Platinum-based Drug [EPC] | 27 |
| 4 | Microtubule Inhibitor [EPC] | 21 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 20 |
| 6 | Prostacycline Vasodilator [EPC] | 18 |
| 7 | Endothelin Receptor Antagonist [EPC] | 17 |
| 8 | Proton Pump Inhibitor [EPC] | 17 |
| 9 | Osmotic Laxative [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 3 | Sodium Channel Blocker [EPC] | 1 | 0.0006 |
| 4 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 5 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 6 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 8 | Calcitonin [EPC] | 1 | 0.0003 |
| 9 | Radiographic Contrast Agent [EPC] | 8 | 0.0003 |